Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,147Revenue $M71.0Net Margin (%)0Z-Score0
Enterprise Value $M1,147EPS $-2.9Operating Margin %0F-Score0
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)0Higher ROA y-yN
Price/Book010-y EBITDA Growth Rate %0Quick Ratio0Cash flow > EarningsN
Price/Sales05-y EBITDA Growth Rate %0Current Ratio0Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)0Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M10.8ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with FURX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
FURXMario Gabelli 2014-06-30 Buy 0.03%$75.24 - $105.3
($97.94)
$ 104.777%New holding54,400
FURXDavid Einhorn 2012-03-31 Sold Out -0.14%$15.83 - $24.64
($17.84)
$ 104.7783%Sold Out0
FURXThird Avenue Management 2010-12-31 Sold Out -0.01%$11.07 - $14.4
($12.5)
$ 104.7788%Sold Out0
FURXThird Avenue Management 2010-09-30 Buy 0.01%$9.42 - $11.94
($10.59)
$ 104.7790%New holding38,789
FURXDavid Einhorn 2010-06-30 Buy 0.15%$9.11 - $11.47
($10.4)
$ 104.7790%New holding490,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

FURX is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


FURX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Forest Laboratories, LLC10% Owner 2014-07-02Buy11,169,066$9510.28 view
Patel SailashCFO 2014-06-24Sell32,928$1040.74 view
COVINGTON PAUL SSenior VP-Clinical Operations 2014-06-24Sell10,368$104.120.62 view
COVINGTON PAUL SSenior VP-Clinical Operations 2014-06-18Sell45,691$104.110.63 view
McIntyre Gail FrancesSenior Vice President-Research 2014-06-17Sell74,457$105.01-0.23 view
COVINGTON PAUL SSenior VP-Clinical Operations 2014-06-13Sell3,228$104.250.5 view
COVINGTON PAUL SSenior VP-Clinical Operations 2014-06-10Sell2,872$104.630.13 view
McIntyre Gail FrancesSenior Vice President-Research 2014-06-10Sell1,746$104.580.18 view
Patel SailashCFO 2014-06-10Sell1,504$104.680.09 view
Almenoff June SheriePresident 2014-02-04Sell115,113$115.29-9.12 view

Press Releases about FURX :

    Quarterly/Annual Reports about FURX:

      News about FURX:

      Articles On GuruFocus.com
      Look at All these Spinoffs Beating the Market Jul 06 2011 

      More From Other Websites
      FURIEX PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement,... Jul 03 2014
      Salix Pharmaceuticals Surges on Positive IBS Data Jul 02 2014
      Actavis Completes Acquisition of Furiex Pharmaceuticals Jul 02 2014
      FURIEX PHARMACEUTICALS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security... Jul 01 2014
      U.S. allows Actavis Plc's purchase of Forest Labs with conditions Jun 30 2014
      Insider Trading Alert - FURX, EGP And FLT Traded By Insiders Jun 13 2014
      FURIEX PHARMACEUTICALS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 28 2014
      SHAREHOLDER ALERT: Brower Piven Announces Class Action Lawsuit in Connection with the Sale of Furiex... May 22 2014
      FURIEX PHARMACEUTICALS, INC. Financials May 16 2014
      INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of Furiex Pharmaceuticals, Inc. of Claims... May 13 2014
      FURIEX PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report May 09 2014
      FURIEX PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... May 07 2014
      Furiex Pharmaceuticals Reports First Quarter 2014 Financial Results May 07 2014
      SHAREHOLDER ALERT: Brower Piven Announces the Investigation of Furiex Pharmaceuticals, Inc. in... May 05 2014
      INVESTOR ALERT – FURIEX PHARMACEUTICALS, INC.: The Law Offices of Vincent Wong Investigates the... May 02 2014
      SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of Furiex Pharmaceuticals, Inc.... May 01 2014
      INVESTOR ALERT - FURIEX PHARMACEUTICALS, INC.: The Law Offices of Vincent Wong Investigates the Sale... Apr 30 2014
      Why traders are buying Furiex puts Apr 30 2014
      Actavis Q1 Earnings Beat On Generic Cymbalta Surprise Apr 30 2014
      Actavis Reporting Q1 Earnings Amid Merger Frenzy Apr 29 2014

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      FEEDBACK